Tilray Inc is a leading pharmaceutical and cannabis company that upholds a strong set of values and corporate philosophy. With a commitment to quality, innovation, and patient care, Tilray strives to provide safe and reliable medical cannabis products to individuals worldwide. The company maintains a focus on science-backed research and development, ensuring the highest standards of cultivation, production, and distribution. Tilray actively promotes transparency, integrity, and ethical practices throughout its operations. By continuously pushing boundaries and fostering collaborations, Tilray aims to improve patient access to medical cannabis, enhance healthcare outcomes, and ultimately make a positive impact on communities globally.

Tilray Inc is primarily present in several countries and regions. As a global cannabis company, Tilray has a significant presence in North America, including the United States and Canada. Furthermore, Tilray Inc has expanded its operations in Europe, particularly in Germany, Portugal, and the United Kingdom. The company's strategic partnerships and acquisitions have also allowed it to establish a foothold in Australia and South America. With its diverse international presence, Tilray Inc has positioned itself as a key player in the global cannabis industry, catering to various markets across continents.

Tilray Inc has achieved several significant milestones in its corporate history. One key achievement includes becoming the first medical cannabis producer to be GMP-certified in North America. Additionally, Tilray secured various partnerships and acquisitions to strengthen its market position and expand its global reach. The company made history by becoming the first Canadian cannabis producer to export medical cannabis to Europe, further solidifying its international presence. Tilray's listing on the NASDAQ stock exchange in 2018 marked another important milestone, showcasing its growth and credibility within the financial markets. With these achievements, Tilray Inc has positioned itself as a leading player in the global cannabis industry.

Tilray Inc is a renowned pharmaceutical and cannabis cultivation company. Established in 2013, Tilray has rapidly become a leading player in the global cannabis industry. The company is based in Canada and operates across various countries including the United States, Australia, Germany, Portugal, and more. Tilray focuses on providing innovative medical cannabis products and research, partnering with universities and researchers to drive advancements in the field. With a strong emphasis on quality and patient care, Tilray Inc has gained a reputation for its superior products and commitment to rigorous testing protocols.

The main competitors of Tilray Inc in the market include Canopy Growth Corporation, Aurora Cannabis Inc, Cronos Group Inc, and Aphria Inc.

Tilray Inc is primarily active in the cannabis industry.

Tilray Inc is a global leader in the production and distribution of cannabis products. The company operates through a vertically integrated business model, which means they handle the entire process from cultivation to distribution. Tilray focuses on creating high-quality medical cannabis products for patients, as well as recreational cannabis products for adult consumers. With state-of-the-art facilities and advanced cultivation techniques, Tilray ensures the consistent production of premium cannabis products. The company's dedication to research and development also allows them to innovate new product offerings and expand their market reach. Tilray Inc's business model aims to meet the growing demand for safe and regulated cannabis products worldwide.

مُعامل القيمة السوقية إلى الأرباح لـ Tilray Brands هو ؜-٢٫١٦.

مُعامِل القيمة إلى المبيعات Tilray Brands هو ٠٫٣٨.

نقاط جودة AlleAktien لـ Tilray Brands هي 3/10.

المتوقعة Tilray Brands الإيرادات هي ٨٨٢٫٠٥ مليون. USD.

صافي الربح المتوقعة Tilray Brands هو ؜-١٥٦٫٥٦ مليون. USD.

Tilray Inc. is a Canada-based global corporation specializing in the production, research, development, and sale of medical cannabis. The company was founded in 2013 and has since achieved immense success. With a presence in over 20 countries, Tilray is currently one of the largest providers of medical cannabis in the global market.

يوزع Tilray Brands أرباحًا قدرها 0 USD من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Tilray Brands في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـTilray Brands هو US88688T1007.

رمز WKN لـ Tilray Brands هو A2JQSC.

الرمز المُختصر لـ Tilray Brands هو TLRY.

خلال آخر 12 شهراً، دفعت Tilray Brands توزيعات أرباح بقيمة . وهذا يعادل عائد توزيعات أرباح يقارب . ومن المتوقع أن تدفع Tilray Brands خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ0 USD.

نسبة توزيعات الأرباح الحالية لـ Tilray Brands هي .

Tilray Brands يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر .

Tilray Brands دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة 0 USD. وهذا يعادل عائد توزيعات أرباح قدره 0 %.

Tilray Brands يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة 0 USD من Tilray Brands المُعلن عنها في ١٨‏/٤‏/٢٠٢٥، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ١٨‏/٤‏/٢٠٢٥.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٨‏/٤‏/٢٠٢٥.

في العام 2024، وزعت Tilray Brands 0 USD كأرباح أسهم.

يتم توزيع أرباح Tilray Brands بالعملة USD.